These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3266762)

  • 41. Endogenous IL-2 production by natural killer cells maintains cytotoxic and proliferative capacity following retroviral-mediated gene transfer.
    Miller JS; Tessmer-Tuck J; Blake N; Lund J; Scott A; Blazar BR; Orchard PJ
    Exp Hematol; 1997 Oct; 25(11):1140-8. PubMed ID: 9328450
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunomodulation of early engrafted natural killer cells with interleukin-2 and interferon-alpha in autologous stem cell transplantation.
    Porrata LF; Inwards DJ; Lacy MQ; Markovic SN
    Bone Marrow Transplant; 2001 Oct; 28(7):673-80. PubMed ID: 11704790
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Killer cell recruitment and renewal capacity of purified cytolytic and noncytolytic human peripheral blood natural killer cell subsets.
    Lebow LT; Jewett A; Bonavida B
    J Immunol; 1993 Jan; 150(1):320-9. PubMed ID: 8417130
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison of the effects of ifosfamide vs. mafosfamide treatment on intracellular glutathione levels and immunological functions of immunocompetent lymphocyte subsets.
    Botzler C; Kis K; Issels R; Multhoff G
    Exp Hematol; 1997 Apr; 25(4):338-44. PubMed ID: 9131009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defective NK cell activity following thermal injury.
    Klimpel GR; Herndon DN; Fons M; Albrecht T; Asuncion MT; Chin R; Stein MD
    Clin Exp Immunol; 1986 Nov; 66(2):384-92. PubMed ID: 3493101
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
    Colotta F; Peri G; Villa A; Mantovani A
    J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pretreatment of human peripheral blood lymphocytes with interleukin-2 or dexamethasone does not alter their response to Met-Enkephalin in a NK-cytotoxic assay.
    Martin-Kleiner I; Gabrilovac J
    Immunopharmacol Immunotoxicol; 1996 Feb; 18(1):37-57. PubMed ID: 8683038
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mode of in vitro augmentation of natural killer cell activity by recombinant human interleukin 2: a comparative study of Leu-11+ and Leu-11- cell populations in cord blood and adult peripheral blood.
    Seki H; Ueno Y; Taga K; Matsuda A; Miyawaki T; Taniguchi N
    J Immunol; 1985 Oct; 135(4):2351-6. PubMed ID: 3928745
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of human natural killer cell reactivity by exogenous adenosine 5'-triphosphate.
    Schmidt A; Ortaldo JR; Herberman RB
    J Immunol; 1984 Jan; 132(1):146-50. PubMed ID: 6690602
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins.
    Gustafsson A; Sundström S; Lundgren E
    J Immunol; 1986 Jul; 137(1):167-71. PubMed ID: 3086447
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Monocyte-mediated augmentation of human natural killer cell activity: conditions, monocyte and effector cell characteristics.
    Bloom ET; Babbitt JT; Kawakami K
    J Immunol; 1986 Jul; 137(1):172-8. PubMed ID: 3711665
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased circulating large granular lymphocytes associated with depressed natural killer cell activity in renal transplant recipients.
    Ramsey KM; Djeu JY; Rook AH
    Transplantation; 1984 Oct; 38(4):351-6. PubMed ID: 6388061
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of X-ray irradiation on natural killer (NK) cell system. I. Elevation of sensitivity of tumor cells and lytic function of NK cells.
    Uchida A; Mizutani Y; Nagamuta M; Ikenaga M
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):507-19. PubMed ID: 2482851
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of human natural killer (NK) activity by calcium channel modulators and a calmodulin antagonist.
    Solovera JJ; Alvarez-Mon M; Casas J; Carballido J; Durantez A
    J Immunol; 1987 Aug; 139(3):876-80. PubMed ID: 2439598
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The proliferation and life-span of rat large granular lymphocytes: effects of cytokines.
    Vaage JT; Reynolds CW; Reynolds D; Fossum S; Rolstad B
    Eur J Immunol; 1989 Oct; 19(10):1895-902. PubMed ID: 2583227
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The functional loss of human natural killer cell activity induced by K562 is reversible via an interleukin-2-dependent mechanism.
    Abrams SI; Brahmi Z
    Cell Immunol; 1986 Sep; 101(2):558-70. PubMed ID: 3489541
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for a beta-adrenoceptor-mediated regulation of human natural killer cells.
    Hellstrand K; Hermodsson S; Strannegård O
    J Immunol; 1985 Jun; 134(6):4095-9. PubMed ID: 2580905
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro modulation of human natural killer cell activity by interferon: generation of adherent suppressor cells.
    Uchida A; Yanagawa E; Kokoschka EM; Micksche M; Koren HS
    Br J Cancer; 1984 Oct; 50(4):483-92. PubMed ID: 6237664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.